Issue 27, 2017

Targeting heparin and heparan sulfate protein interactions

Abstract

Heparin and heparan sulfate glycosaminoglycans are long, linear polysaccharides that are made up of alternating dissacharide sequences of sulfated uronic acid and amino sugars. Unlike heparin, which is only found in mast cells, heparan sulfate is ubiquitously expressed on the cell surface and in the extracellular matrix of all animal cells. These negatively-charged glycans play essential roles in important cellular functions such as cell growth, adhesion, angiogenesis, and blood coagulation. These biomolecules are also involved in pathophysiological conditions such as pathogen infection and human disease. This review discusses past and current methods for targeting these complex biomolecules as a novel therapeutic strategy to treating disorders such as cancer, neurodegenerative diseases, and infection.

Graphical abstract: Targeting heparin and heparan sulfate protein interactions

Article information

Article type
Review Article
Submitted
02 May 2017
Accepted
13 Jun 2017
First published
13 Jun 2017

Org. Biomol. Chem., 2017,15, 5656-5668

Targeting heparin and heparan sulfate protein interactions

R. J. Weiss, J. D. Esko and Y. Tor, Org. Biomol. Chem., 2017, 15, 5656 DOI: 10.1039/C7OB01058C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements